Catalyst Wire Dossier Catalyst Wire Dossier

MELT-300

· Melt Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MELT-300, covering 2022-12-19 to 2024-08-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR) [Phase 3]

See pricing